Hawthorne Direct, Inc. – Trademark Portfolio
Entity Type: 03
Hawthorne Direct, Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 16 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PURESTAT, HAWTHORNE DIRECT, and THE ART OF BRAND THE SCIENCE OF RESPONSE. The owner is based in Los Angeles, CA.
1201 West 5th Street, Suite T230
Los Angeles, CA 90017
Showing of trademarks Trademarks
Trademark Classifications
Hawthorne Direct, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Hawthorne Direct, Inc. have?
Hawthorne Direct, Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned, 9 cancelled.
What trademark classes does Hawthorne Direct, Inc. file in?
Hawthorne Direct, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Hawthorne Direct, Inc.'s most well-known trademarks?
Hawthorne Direct, Inc.'s registered trademark portfolio includes well-known marks such as PURESTAT, HAWTHORNE DIRECT, and THE ART OF BRAND THE SCIENCE OF RESPONSE. These are among 3 currently registered trademarks in the portfolio.
What is Hawthorne Direct, Inc.'s trademark registration success rate?
Hawthorne Direct, Inc. has a 17% trademark registration rate, with 3 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.